Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
1375182 | Bioorganic & Medicinal Chemistry Letters | 2006 | 5 Pages |
Abstract
A series of novel oxyindole-derived HIV-1 protease inhibitors were designed and synthesized based upon our X-ray crystal structure of inhibitor 2 (TMC-114) bound to HIV-1 protease. The effects of substituents, spirocyclic rings, and ring sizes have been investigated. A number of inhibitors exhibited low nanomolar inhibitory potencies against HIV protease.
Graphical abstractA series of novel oxyindole-derived HIV-1 protease inhibitors were designed and synthesized. A number of inhibitors exhibited low nanomolar inhibitory potencies against HIV protease.Figure optionsDownload full-size imageDownload as PowerPoint slide
Keywords
Related Topics
Physical Sciences and Engineering
Chemistry
Organic Chemistry
Authors
Arun K. Ghosh, Gary Schiltz, Ramu Sridhar Perali, Sofiya Leshchenko, Stephanie Kay, D. Eric Walters, Yasuhiro Koh, Kenji Maeda, Hiroaki Mitsuya,